Supply of various medicinal products for FHL
Original notice title
Luxembourg – Various medicinal products – Centrale d'achat FHL: fourniture de médicaments divers.
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Fédération des Hôpitaux Luxembourgeois (FHL)
- Country
- Luxembourg
- CPV
- 33690000 - Various medicinal products
- Deadline
- Jul 31, 2026
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Buyer
Location
Bertrange, LUX
Identifier
LU23830047
Activity
Health
Lots (9)
LOT-0001
Rituximab, forme injectable intraveineuse, 500 mg
Rituximab, forme injectable intraveineuse, 500 mg.
Location
Duration
Category
Award details
Rituximab, forme injectable intraveineuse, 500 mg.
LOT-0002
Trastuzumab, forme injectable intraveineuse, 420 mg
Trastuzumab, forme injectable intraveineuse, 420 mg.
Location
Duration
Category
Award details
Trastuzumab, forme injectable intraveineuse, 420 mg.
LOT-0003
Pirfenidone, formes orales sèches, 267 mg et 801 mg
Pirfenidone, formes orales sèches, 267 mg et 801 mg.
Location
Duration
Category
Award details
Pirfenidone, formes orales sèches, 267 mg et 801 mg.
LOT-0004
Nilotinib, formes orales sèches, 150 mg et 200 mg
Nilotinib, formes orales sèches, 150 mg et 200 mg.
Location
Duration
Category
Award details
Nilotinib, formes orales sèches, 150 mg et 200 mg.
LOT-0005
Dabigatran etexilate, formes orales sèches, 75 mg, 110 mg et 150 mg
Dabigatran etexilate, formes orales sèches, 75 mg, 110 mg et 150 mg.
Location
Duration
Category
Award details
Dabigatran etexilate, formes orales sèches, 75 mg, 110 mg et 150 mg.
LOT-0006
Tocilizumab, formes injectables intraveineuses, 10 ml et 20 ml
Tocilizumab, formes injectables intraveineuses, 10 ml et 20 ml.
Location
Duration
Category
Award details
Tocilizumab, formes injectables intraveineuses, 10 ml et 20 ml.
LOT-0007
Atosiban, formes injectables intraveineuses, 0,9 ml et 5 ml
Atosiban, formes injectables intraveineuses, 0,9 ml et 5 ml.
Location
Duration
Category
Award details
Atosiban, formes injectables intraveineuses, 0,9 ml et 5 ml.
LOT-0008
Pertuzumab, forme injectable intraveineuse, 420 mg, 420mg/14ml
Pertuzumab, forme injectable intraveineuse, 420 mg, 20mg/14ml.
Location
Duration
Category
Award details
Pertuzumab, forme injectable intraveineuse, 420 mg, 20mg/14ml.
LOT-1000
Espace de remise des offres
Espace de remise des offres.
Location
Duration
Category
Award details
Espace de remise des offres.
Procurement Details
- Publication date
- 28 Jun 2026
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 444995-2026
Documents (1)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications